215 related articles for article (PubMed ID: 22155187)
1. A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection.
Yang J; Li L; Tan S; Jin H; Qiu J; Mao Q; Li R; Xia C; Jiang ZH; Jiang S; Liu S
Fitoterapia; 2012 Mar; 83(2):348-55. PubMed ID: 22155187
[TBL] [Abstract][Full Text] [Related]
2. Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41.
Liu S; Lu H; Zhao Q; He Y; Niu J; Debnath AK; Wu S; Jiang S
Biochim Biophys Acta; 2005 May; 1723(1-3):270-81. PubMed ID: 15823507
[TBL] [Abstract][Full Text] [Related]
3. Vaginal gel formulation based on theaflavin derivatives as a microbicide to prevent HIV sexual transmission.
Yang J; Li L; Jin H; Tan S; Qiu J; Yang L; Ding Y; Jiang ZH; Jiang S; Liu S
AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1498-508. PubMed ID: 22867271
[TBL] [Abstract][Full Text] [Related]
4. Antiviral activity of theaflavin digallate against herpes simplex virus type 1.
de Oliveira A; Prince D; Lo CY; Lee LH; Chu TC
Antiviral Res; 2015 Jun; 118():56-67. PubMed ID: 25818500
[TBL] [Abstract][Full Text] [Related]
5. In vitro anti-influenza virus and anti-inflammatory activities of theaflavin derivatives.
Zu M; Yang F; Zhou W; Liu A; Du G; Zheng L
Antiviral Res; 2012 Jun; 94(3):217-24. PubMed ID: 22521753
[TBL] [Abstract][Full Text] [Related]
6. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
Hamza A; Zhan CG
J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
[TBL] [Abstract][Full Text] [Related]
7. [1,2,6-tri-O-galloyl-beta-D-glucopyranose inhibits gp41-mediated HIV envelope fusion with target cell membrane].
Sun W; Wang HT; Xia CL; Wu SG; Jiang SB; Jiang ZH; Liu SW
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1127-31. PubMed ID: 18676243
[TBL] [Abstract][Full Text] [Related]
8. Tannin inhibits HIV-1 entry by targeting gp41.
Lü L; Liu SW; Jiang SB; Wu SG
Acta Pharmacol Sin; 2004 Feb; 25(2):213-8. PubMed ID: 14769212
[TBL] [Abstract][Full Text] [Related]
9. Theaflavins, polyphenols of black tea, inhibit entry of hepatitis C virus in cell culture.
Chowdhury P; Sahuc ME; Rouillé Y; Rivière C; Bonneau N; Vandeputte A; Brodin P; Goswami M; Bandyopadhyay T; Dubuisson J; Séron K
PLoS One; 2018; 13(11):e0198226. PubMed ID: 30485282
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of pancreatic lipase by black tea theaflavins: Comparative enzymology and in silico modeling studies.
Glisan SL; Grove KA; Yennawar NH; Lambert JD
Food Chem; 2017 Feb; 216():296-300. PubMed ID: 27596423
[TBL] [Abstract][Full Text] [Related]
11. Theaflavins from black tea, especially theaflavin-3-gallate, reduce the incorporation of cholesterol into mixed micelles.
Vermeer MA; Mulder TP; Molhuizen HO
J Agric Food Chem; 2008 Dec; 56(24):12031-6. PubMed ID: 19049290
[TBL] [Abstract][Full Text] [Related]
12. Combination of HSCCC and Sephadex LH-20 methods An approach to isolation and purification of the main individual theaflavins from black tea.
Yang C; Li D; Wan X
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jan; 861(1):140-4. PubMed ID: 18063426
[TBL] [Abstract][Full Text] [Related]
13. Diverse inhibition of plasminogen activator inhibitor type 1 by theaflavins of black tea.
Jankun J; Skotnicka M; Łysiak-Szydłowska W; Al-Senaidy A; Skrzypczak-Jankun E
Int J Mol Med; 2011 Apr; 27(4):525-9. PubMed ID: 21308350
[TBL] [Abstract][Full Text] [Related]
14. Catechins containing a galloyl moiety as potential anti-HIV-1 compounds.
Zhao Y; Jiang F; Liu P; Chen W; Yi K
Drug Discov Today; 2012 Jun; 17(11-12):630-5. PubMed ID: 22414543
[TBL] [Abstract][Full Text] [Related]
15. Theaflavins from black tea affect growth, development, and motility in Dictyostelium discoideum.
Ilacqua AN; Shettler JA; Wernke KM; Skalla JK; McQuade KJ
Biochem Biophys Res Commun; 2017 Sep; 491(2):449-454. PubMed ID: 28711497
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 gp41: mediator of fusion and target for inhibition.
Weiss CD
AIDS Rev; 2003; 5(4):214-21. PubMed ID: 15012000
[TBL] [Abstract][Full Text] [Related]
17. HIV type-1 entry inhibitors with a new mode of action.
Fink RC; Roschek B; Alberte RS
Antivir Chem Chemother; 2009; 19(6):243-55. PubMed ID: 19641233
[TBL] [Abstract][Full Text] [Related]
18. Amino acid derivatives of the (-) enantiomer of gossypol are effective fusion inhibitors of human immunodeficiency virus type 1.
An T; Ouyang W; Pan W; Guo D; Li J; Li L; Chen G; Yang J; Wu S; Tien P
Antiviral Res; 2012 Jun; 94(3):276-87. PubMed ID: 22426469
[TBL] [Abstract][Full Text] [Related]
19. Feglymycin, a unique natural bacterial antibiotic peptide, inhibits HIV entry by targeting the viral envelope protein gp120.
Férir G; Hänchen A; François KO; Hoorelbeke B; Huskens D; Dettner F; Süssmuth RD; Schols D
Virology; 2012 Nov; 433(2):308-19. PubMed ID: 22959895
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the growth-inhibitory and apoptosis-inducing activities of black tea theaflavins and green tea catechin on murine myeloid leukemia cells.
Lung HL; Ip WK; Chen ZY; Mak NK; Leung KN
Int J Mol Med; 2004 Mar; 13(3):465-71. PubMed ID: 14767581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
